Standard InChI: InChI=1S/C24H19N3O/c1-2-8-18(9-3-1)28-19-10-6-7-17(13-19)15-25-24-14-21-20-11-4-5-12-22(20)27-23(21)16-26-24/h1-14,16,27H,15H2,(H,25,26)
1.Ikeda R, Kurosawa M, Okabayashi T, Takei A, Yoshiwara M, Kumakura T, Sakai N, Funatsu O, Morita A, Ikekita M, Nakaike Y, Konakahara T.. (2011) 3-(3-Phenoxybenzyl)amino-β-carboline: a novel antitumor drug targeting α-tubulin., 21 (16):[PMID:21752645][10.1016/j.bmcl.2011.06.061]
2.Ikeda R, Kimura T, Tsutsumi T, Tamura S, Sakai N, Konakahara T.. (2012) Structure-activity relationship in the antitumor activity of 6-, 8- or 6,8-substituted 3-benzylamino-β-carboline derivatives., 22 (10):[PMID:22520257][10.1016/j.bmcl.2012.03.077]
3.Li Y, Liu Y, Zhu Z, Yan W, Zhang C, Yang Z, Bai P, Tang M, Shi M, He W, Fu S, Liu J, Han K, Li J, Xie L, Ye H, Yang J, Chen L.. (2022) Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents., 65 (3.0):[PMID:35084853][10.1021/acs.jmedchem.1c02159]
4.Yang J, Li Y, Qiu Q, Wang R, Yan W, Yu Y, Niu L, Pei H, Wei H, Ouyang L, Ye H, Xu D, Wei Y, Chen Q, Chen L.. (2022) Small Molecules Promote Selective Denaturation and Degradation of Tubulin Heterodimers through a Low-Barrier Hydrogen Bond., 65 (13.0):[PMID:35762925][10.1021/acs.jmedchem.2c00379]
